Dr. Husain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3855 Health Sciences #3011
San Diego, CA 92121Phone+1 858-822-5182
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2009 - 2012
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2005 - 2008
Northwestern University The Feinberg School of MedicineClass of 2005
Certifications & Licensure
CA State Medical License 2007 - 2025
MD State Medical License 2009 - 2018
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC Start of enrollment: 2019 Aug 14
- Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osimertinib Resistance Start of enrollment: 2020 Nov 21
Publications & Presentations
PubMed
- 287 citationsAn integrin β 3 –KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibitionLaetitia Seguin, Shumei Kato, Aleksandra Franovic, M. Fernanda Camargo, Jacqueline Lesperance
Nature Cell Biology. 2014-05-01 - 683 citationsGenome-wide cell-free DNA fragmentation in patients with cancerStephen Cristiano, Alessandro Leal, Jillian Phallen, Jacob Fiksel, Vilmos Adleff
Nature. 2019-06-20 - 254 citationsEGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical OutcomesNicolas Marcoux, Scott N. Gettinger, Grainne M. O'Kane, Kathryn C. Arbour, Joel W. Neal
Journal of Clinical Oncology. 2019-02-01
Press Mentions
Dr. Husain on Liquid Biopsy Versus Tissue Biopsy in NSCLCFebruary 19th, 2020
TROVAGENE : Other Events (Form 8-K)August 1st, 2015
Certain Targeted Cancer Drugs Promoting Drug-Resistance, Tumor GrowthMay 7th, 2014- Join now to see all
Other Languages
- Spanish, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
